Botanix Pharmaceuticals Limited

Botanix Pharmaceuticals is a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers.

Its portfolio also includes BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus, BTX 1702 for the treatment of papulopustular rosacea, and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in Melbourne, Australia.